A Multi-center Cohort Study of Hydatidiform Mole in China (CN-HM-01)
NCT07202728 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1489
Last updated 2025-10-02
Summary
This observational study aims to establish a national cohort of patients with hydatidiform mole (molar pregnancy) to investigate its malignant transformation rate and malignant transformation mechanisms, with the goal of developing and promoting precision diagnosis and treatment models across China.
Conditions
- Hydatidiform Mole
Interventions
- OTHER
-
No intervention
No intervention
Sponsors & Collaborators
-
Peking Union Medical College Hospital
collaborator OTHER -
Shengjing Hospital
collaborator OTHER -
Hebei Medical University Third Hospital
collaborator OTHER -
Hainan women and children medical center
collaborator UNKNOWN -
Shenzhen Maternity & Child Healthcare Hospital
collaborator OTHER -
Third Affiliated Hospital of Zhengzhou University
collaborator OTHER -
Shanghai First Maternity and Infant Hospital
collaborator OTHER -
International Peace Maternity and Child Health Hospital
collaborator OTHER -
Shandong University
collaborator OTHER -
First Affiliated Hospital of Zhejiang University
collaborator OTHER -
The Affiliated Hospital of Qingdao University
collaborator OTHER -
Gansu Provincial Maternity and Child-care Hospital/Gansu Provincial Central Hospital
collaborator UNKNOWN -
Dalian women and children's medical group
collaborator UNKNOWN -
Obstetrics & Gynecology Hospital of Fudan University
lead OTHER
Principal Investigators
-
Xin Lu, MD & PhD · Obstetrics & Gynecology Hospital of Fudan University
-
Yang Xiang, MD & PhD · Peking Union Medical College Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-09
- Primary Completion
- 2028-08-30
- Completion
- 2030-08-30
Countries
- China
Study Locations
More Related Trials
-
Clinical Study of SM3321 With Solid Tumors
NCT06087770 ·Status: RECRUITING ·Phase: PHASE1
-
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
NCT06363123 ·Status: RECRUITING
-
PET/MR in Locally Advanced Nasopharyngeal Carcinoma
NCT03657017 ·Status: RECRUITING ·Phase: NA
-
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
NCT06010875 ·Status: RECRUITING ·Phase: PHASE1
-
Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor
NCT05490667 ·Status: UNKNOWN ·Phase: NA
-
Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors
NCT04952272 ·Status: RECRUITING ·Phase: PHASE1
-
A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T
NCT05468190 ·Status: UNKNOWN ·Phase: PHASE1
-
GP-induced Chemotherapy Combined With IMRT and TPF-induced Chemotherapy Combined With IMRT in the Treatment of Distant Metastatic Nasopharyngeal Carcinoma
NCT03723343 ·Status: UNKNOWN
-
A Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With Solid Tumors
NCT06101082 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of BL-M07D1 Combination Therapy in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma
NCT06423885 ·Status: RECRUITING ·Phase: PHASE2
-
Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort Study
NCT07270861 ·Status: RECRUITING
-
Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC
NCT06197776 ·Status: RECRUITING
-
A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies
NCT05803018 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors
NCT07181720 ·Status: RECRUITING ·Phase: PHASE1
-
Expression of ANXA2 in the Extracellular Space in the Microenvironment of Periumoral Edema Promotes Glioma Invasion
NCT04953468 ·Status: UNKNOWN
-
Phase I Clinical Study of BL-M07D1 in Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors
NCT05631964 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors
NCT06954077 ·Status: RECRUITING ·Phase: PHASE1
-
Postoperative CCRT Followed by Immunotherapy in High-Risk LA HNSCC
NCT06170710 ·Status: RECRUITING ·Phase: PHASE2
-
A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT07050459 ·Status: RECRUITING ·Phase: PHASE1
-
MASCT-I in Patients With Metastatic or Recurrent Solid Tumors Who Failed Standard Therapy.
NCT05877651 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of BL-M07D1 in Patients With HER2-mutated, Locally Advanced or Metastatic Non-small-cell Lung Cancer
NCT06114511 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Application of 68Ga-NODAGA-SNA006 Positron Emission Tomography/Computed Tomography (PET/CT) in Tumors
NCT07059832 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer
NCT06195228 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of BL-M08D1 in Patients With Locally Advanced or Metastatic Solid Tumors
NCT06718621 ·Status: RECRUITING ·Phase: PHASE1
-
Study of GV20-0251 in Participants With Solid Tumor Malignancies
NCT07070518 ·Status: RECRUITING ·Phase: PHASE1/PHASE2